Funding - July 23, 2020
1.25 million NOK to PDT/PCI research in Norway
Radforsk has granted seven research projects a total amount of MNOK 1,25 to further develop exciting research projects within photodynamic treatment (PDT) and photochemical internalization (PCI). Radforsk is an evergreen investor focusing on companies that develop cancer treatments. “Radforsk has ploughed NOK 200 million of its profit back into cancer research at Oslo University Hospital. […]
Collaboration - June 11, 2020
Nordic initiative offers courses in health innovation
The School of Health Innovation, founded by Karolinska Institutet, KI, Oslo University, UiO, and Norwegian University of Science and Technology NTNU, is the first Nordic initiative to offer courses in innovation as an extension of the academic subjects health sciences and life sciences. In addition, the University of Copenhagen will be joining the initiative shortly […]
In a new job - June 5, 2020
Exact Therapeutics appoints new CEO
Exact Therapeutics has announced that it has appointed Dr Rafiq Hasan as CEO. Rafiq Hasan joins as the GE Healthcare spin-out, formerly known as Phoenix Solutions, reports strong progress in its First in Man ACTivate-trial (NCT04021277), investigating ACT combination with standard of care chemotherapy for the treatment of hepatic metastases secondary to colorectal and pancreatic […]
Pharma Business - May 25, 2020
Vaccibody initiates research in infectious diseases
Vaccibody expands the utilization of its technology platform into the area of infectious diseases in order to explore opportunities in this field of significant unmet medical needs. Dr. Gunnstein Norheim, former Director of Vaccine Science at Coalition for Epidemic Preparedness Innovations (CEPI), is appointed to lay out the strategy and lead Vaccibody’s research initiative within […]
Financing - April 24, 2020
Bio-Me receives 2 million EUR in public funding
Bio-Me has received a total of 2 million EUR in grants and public support from the Norwegian Research Council to develop a companion diagnostic test for immune checkpoint inhibitor (ICI) cancer treatments. Bio-Me will use its PMP – Precision Microbiome Profiling technology – to develop a microbiome-based test that can identify responders to ICI. Test […]
Uncategorized - April 16, 2020
A Health Catapult Centre is taking shape in Norway
Three Norwegian health innovation clusters will collaborate on forming a concept for the first Norwegian Health Catapult Centre, with the aim to support innovative SMEs. Siva, a governmental enterprise facilitating a national infrastructure for innovation, has selected Oslo Cancer Cluster Incubator, Norway Health Tech and Norwegian Smart Care Cluster to proceed to the next round […]
